KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Payout Ratio (2016 - 2026)

Eli Lilly filings provide 18 years of FCF Payout Ratio readings, the most recent being 0.51 for Q1 2026.

  • On a quarterly basis, FCF Payout Ratio fell 94.03% to 0.51 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.47, a 63.65% decrease, with the full-year FY2025 number at 0.6, down 51.79% from a year prior.
  • FCF Payout Ratio hit 0.51 in Q1 2026 for Eli Lilly, down from 1.98 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 8.63 in Q1 2025 to a low of 19.13 in Q2 2023.
  • Median FCF Payout Ratio over the past 5 years was 0.83 (2023), compared with a mean of 0.66.
  • Biggest five-year swings in FCF Payout Ratio: crashed 980.17% in 2023 and later soared 579.36% in 2024.
  • Eli Lilly's FCF Payout Ratio stood at 0.76 in 2022, then plummeted by 196.69% to 0.74 in 2023, then soared by 262.32% to 1.19 in 2024, then soared by 66.16% to 1.98 in 2025, then tumbled by 74.06% to 0.51 in 2026.
  • The last three reported values for FCF Payout Ratio were 0.51 (Q1 2026), 1.98 (Q4 2025), and 0.2 (Q3 2025) per Business Quant data.